journal article Jul 22, 2008

Nigral burden of α‐synuclein correlates with striatal dopamine deficit

Movement Disorders Vol. 23 No. 11 pp. 1608-1612 · Wiley
View at Publisher Save 10.1002/mds.22207
Abstract
AbstractAggregated α‐synuclein is the hallmark of Parkinson's disease (PD), diffuse Lewy body disease (DLBD), and multiple system atrophy (MSA). Physiologically, α‐synuclein ensures normal functions of dopamine transporter (DAT) and tyrosine hydoxylase. In α‐synucleinopathies, it accumulates in neuronal cytoplasm and neurites through several stages. It is unclear whether the accumulation of pathological α‐synuclein in the substantia nigra in PD correlates with the dopaminergic deficit in the striatal target. We evaluated the impact of the nigral burden of pathological α‐synuclein immunoreactivity in 27 α‐synucleinopathy brains by morphometric immunohistochemistry. DAT immunoreactivity in the striatum inversely correlates with the total α‐synuclein burden in the substantia nigra but not with cytoplasmic inclusion counts only. This result has implications for imaging, clinicopathological correlative studies, and staging of the disease process. © 2008 Movement Disorder Society
Topics

No keywords indexed for this article. Browse by subject →

Metrics
50
Citations
15
References
Details
Published
Jul 22, 2008
Vol/Issue
23(11)
Pages
1608-1612
License
View
Cite This Article
Gabor G. Kovacs, Ivan J. Milenkovic, Matthias Preusser, et al. (2008). Nigral burden of α‐synuclein correlates with striatal dopamine deficit. Movement Disorders, 23(11), 1608-1612. https://doi.org/10.1002/mds.22207